CDKN2A and vulva cancer: The impact of p16Ink4a -status on vulvar cancer immune surveillance as represented by tumor-infiltrating lymphocytes (TILs) and tumor associated macrophages (TAMs) is unknown and potentially could be correlated with the outcome of patients.